Effects of an olmesartan medoxomil based treatment algorithm on 24-hour blood pressure control in patients with hypertension and type 2 diabetes.

@article{Neutel2010EffectsOA,
  title={Effects of an olmesartan medoxomil based treatment algorithm on 24-hour blood pressure control in patients with hypertension and type 2 diabetes.},
  author={Joel M. Neutel and Dean J Kereiakes and William F Waverczak and Kathy A Stoakes and Jianbo Xu and Ali Habibzade Shojaee},
  journal={Current medical research and opinion},
  year={2010},
  volume={26 3},
  pages={721-8}
}
OBJECTIVE The BENIFICIARY (BENIcar safety and efFICacy evaluatIon: An open-label, single-ARm, titration study in patients with hypertension and tYpe 2 diabetes) study was conducted to evaluate the efficacy and safety of olmesartan medoxomil (OM) plus hydrochlorothiazide (HCTZ) in patients with hypertension and type 2 diabetes. RESEARCH DESIGN AND METHODS After a placebo run-in period, 192 patients received OM 20 mg/day for 3 weeks. If blood pressure (BP) remained > or =120/70 mm Hg, patients… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

Monotherapy and Dual Combination Therapies Based on Olmesartan: A Comprehensive Strategy to Improve Blood Pressure Control.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension • 2017
View 7 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…